ValueWorks’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,158
Closed -$997K 36
2020
Q1
$997K Sell
10,158
-501
-5% -$65.7K 0.97% 26
2019
Q4
$1.55M Sell
10,659
-334
-3% -$46.1K 0.97% 28
2019
Q3
$1.47M Sell
10,993
-5,175
-32% -$668K 0.99% 28
2019
Q2
$1.85M Sell
16,168
-103
-0.6% -$12.1K 1.22% 25
2019
Q1
$2.02M Buy
16,271
+27
+0.2% +$3.07K 1.35% 25
2018
Q4
$1.64M Sell
16,244
-1,632
-9% -$184K 1.12% 29
2018
Q3
$2.28M Sell
17,876
-2,316
-11% -$275K 1.44% 25
2018
Q2
$2.18M Sell
20,192
-335
-2% -$36.5K 1.4% 25
2018
Q1
$2.17M Sell
20,527
-751
-4% -$87.2K 1.66% 22
2017
Q4
$2.49M Sell
21,278
-333
-2% -$37.7K 1.85% 21
2017
Q3
$2.46M Buy
+21,611
New +$2.49M 1.75% 22
2017
Q2
Sell
-21,945
Closed -$2.6M 36
2017
Q1
$2.6M Sell
21,945
-1,829
-8% -$207K 2% 24
2016
Q4
$2.38M Sell
23,774
-205
-0.9% -$22K 1.87% 24
2016
Q3
$3.03M Sell
23,979
-821
-3% -$101K 2.69% 19
2016
Q2
$2.9M Sell
24,800
-1,248
-5% -$141K 2.47% 21
2016
Q1
$2.7M Sell
26,048
-529
-2% -$51.2K 2.31% 20
2015
Q4
$2.65M Sell
26,577
-4,325
-14% -$423K 2.16% 21
2015
Q3
$2.82M Sell
30,902
-1,720
-5% -$172K 1.98% 22
2015
Q2
$3.46M Sell
32,622
-616
-2% -$68.2K 1.96% 21
2015
Q1
$3.79M Sell
33,238
-5,759
-15% -$657K 2% 22
2014
Q4
$4.29M Sell
38,997
-3,020
-7% -$318K 2.12% 23
2014
Q3
$4.1M Sell
42,017
-192
-0.5% -$18.9K 2.11% 23
2014
Q2
$4.26M Sell
42,209
-1,211
-3% -$118K 2.03% 24
2014
Q1
$3.99M Sell
43,420
-309
-0.7% -$28.5K 2.35% 19
2013
Q4
$3.96M Sell
43,729
-489
-1% -$42.3K 2.15% 22
2013
Q3
$3.53M Sell
44,218
-284
-0.6% -$22.4K 2.17% 22
2013
Q2
$3.24M Buy
+44,502
New +$3.33M 1.88% 25

Other funds holding ZBH

ValueWorks's ZBH Position: Q2 2020 in Review

ValueWorks sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 10,158 shares — an estimated $997K sold.

ValueWorks first reported a position in ZBH in Q2 2013 and held it in 27 quarters. The position peaked at $4.29M in Q4 2014. 945 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • ValueWorks reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
  • ValueWorks sold 10,158 Zimmer Biomet shares in Q2 2020, an estimated $997K.
  • ValueWorks first reported a position in Zimmer Biomet in Q2 2013 and held it in 27 quarters.
  • ValueWorks's Zimmer Biomet position peaked at $4.29M in Q4 2014.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on ValueWorks's 13F filing for Q2 2020, filed 14 Aug 2020.